Skip to content
Research Article Open access CC BY 4.0

Epidemiological Trends of Lassa Fever Outbreaks and Insights for Future Control in Nigeria

J. O. Olayiwola, A. S. Bakarey

International Journal of TROPICAL DISEASE & Health · pp. 1–14 · Published 28 Jul 2017

10.9734/IJTDH/2017/32823

Abstract

The pattern of Lassa fever outbreaks in Nigeria over the years is worrisome and increasingly becoming more challenging with frequent and widening geographical spread. Lassa fever is endemic and fast becoming hyper-endemic in Nigeria. It affects the largest number of people, creating a geographical network of endemic foci encompassing a population of perhaps 180 million from Guinea to Nigeria. Lassa fever presents signs and symptoms indistinguishable from those of febrile illnesses such as malaria and other viral haemorrhagic fevers such as Ebola. Frequent human exposure to the virus is therefore possible due to the human population explosion in the endemic area and therefore given opportunities for infection with this virus, and subsequently the disease. Clinical diagnosis of Lassa fever is difficult however it should be suspected in patients showing fever with temperature (≥ 38°C) not responding adequately to antimalarial and antibiotic treatments. Laboratory diagnosis by serological, cell culture and molecular techniques is reliable although very expensive. For now there is supportive treatment but no licensed vaccine yet; therefore, public awareness and advocacy are vital in educating and sensitizing the citizenry on the risk associated with overcrowding and unhygienic practices both in our communities and health institutions in Nigeria and its environs. This review summarizes the trends and pattern of outbreaks of Lassa fever in Nigeria and other aspects of diagnosis and prevention including reasons for the lack of a vaccine and proposes plans to prevent future outbreaks.

Lassa virus haemorrhagic fever laboratory diagnosis endemic Nigeria

References (36)

  1. 1 Biosafety in microbiological and biomedical laboratories
  2. 2 Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak [DOI]
  3. 3 Identification of α-Dystroglycan as a Receptor for Lymphocytic Choriomeningitis Virus and Lassa Fever Virus [DOI]
  4. 4 A Prospective Study of the Epidemiology and Ecology of Lassa Fever [DOI]
  5. 5 Lassa Fever, a New Virus Disease of Man from West Africa [DOI]
  6. 6 Rapid Diagnosis of Ebola Hemorrhagic Fever by Reverse Transcription-PCR in an Outbreak Setting and Assessment of Patient Viral Load as a Predictor of Outcome [DOI]
  7. 7 A Case-Control Study of the Clinical Diagnosis and Course of Lassa Fever [DOI]
  8. 8 Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice [DOI]
  9. 9 Lassa Virus Isolation from Mastomys natalensis Rodents during an Epidemic in Sierra Leone [DOI]
  10. 10 Genetic Diversity among Lassa Virus Strains [DOI]
  11. 11 Lassa fever in West African sub-region: an overview.
  12. 12 Acute Sensorineural Deafness in Lassa Fever [DOI]
  13. 13 Imported Lassa Fever in Germany: Molecular Characterization of a New Lassa Virus Strain [DOI]
  14. 14 Diagnosis and Clinical Virology of Lassa Fever as Evaluated by Enzyme-Linked Immunosorbent Assay, Indirect Fluorescent-Antibody Test, and Virus Isolation [DOI]
  15. 15 Rapid Molecular Assays for the Detection of Yellow Fever Virus in Low-Resource Settings [DOI]
  16. 16 Lassa Fever, a New Virus Disease of Man from West Africa [DOI]
  17. 17 Phylogenetic Analysis of theArenaviridae:Patterns of Virus Evolution and Evidence for Cospeciation between Arenaviruses and Their Rodent Hosts [DOI]
  18. 18 Pathologic and virologic study of fatal Lassa fever in man.
  19. 19 Lassa fever: review of epidemiology and epizootiology.
  20. 20 Isolation of an arenavirus closely related to Lassa virus from Mastomys natalensis in south-east Africa.
  21. 21 Characterization of the Interaction of Lassa Fever Virus with Its Cellular Receptor α-Dystroglycan [DOI]
  22. 22 Viral Hemorrhagic Fever Antibodies in Nigerian Populations [DOI]
  23. 23 Lassa virus activity in Guinea: Distribution of human antiviral antibody defined using enzyme‐linked immunosorbent assay with recombinant antigen [DOI]
  24. 24 Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA [DOI]
  25. 25 Lassa fever vaccine [DOI]
  26. 26 Old World and Clade C New World Arenaviruses Mimic the Molecular Mechanism of Receptor Recognition Used by α-Dystroglycan's Host-Derived Ligands [DOI]
  27. 27 Cell Culture and Electron Microscopy for Identifying Viruses in Diseases of Unknown Cause [DOI]
  28. 28 Testing and Validation of High Density Resequencing Microarray for Broad Range Biothreat Agents Detection [DOI]
  29. 29 Old World Arenavirus Infection Interferes with the Expression of Functional α-Dystroglycan in the Host Cell [DOI]
  30. 30 Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies [DOI]
  31. 31 Characterization of arenaviruses using a family-specific primer set for RT-PCR amplification and RFLP analysis [DOI]
  32. 32 Surveillance of Lassa fever in missionaries stationed in West Africa.
  33. 33 Development and evaluation of a broad reacting SYBR-green based quantitative real-time PCR for the detection of different hantaviruses [DOI]
  34. 34 Post-translational modification of α-dystroglycan is not critical for lymphocytic choriomeningitis virus receptor function in vivo [DOI]
  35. 35 Electron microscopy of an α-dystroglycan fragment containing receptor sites for lymphocytic choriomeningitis virus and laminin, and use of the receptoid body as a reagent to neutralize virus [DOI]
  36. 36 Mapping Arenavirus Genes Causing Virulence [DOI]

Cited by 39

Lassa fever in West Africa: a systematic review and meta-analysis of attack rates, case fatality rates and risk factors

Grace Opeoluwa Ogundele, Kelvin Olutimilehin Jolayemi, Segun Bello · BMC Public Health · 2025

Correlates of Emergency Preparedness and Response to Disease Outbreaks in Kano, Northwest Nigeria

Abba Ahmed Danzomo, Boateng Kofi, Sunday Audu · Nigerian Postgraduate Medical Journal · 2025

Computational Approximations for Real-World Application of Epidemic Model

Shami A. M. Alsallami, Ali Raza, Mona Elmahi · Intelligent Automation & Soft Computing · 2022

Epidemiology and Comprehensive Review on the Myth and Facts of Lassa Fever Transmission

Iyevhobu Kenneth Oshiokhayamhe, Okparaku Sunday Onyemaechi, Asibor Ernest · Asian Journal of Biological Sciences · 2024

Re-emerging Lassa fever outbreaks in Nigeria: Re-enforcing “One Health” community surveillance and emergency response practice

Ernest Tambo, Oluwasegun T. Adetunde, Oluwasogo A. Olalubi · Infectious Diseases of Poverty · 2018

Analysis of National Lassa fever Surveillance Data, Sierra Leone, 2012 - 2018

Kassim Kamara · Journal of Interventional Epidemiology and Public Health · 2023

Ecology of Lassa Virus

Allison R. Smither, Antoinette R. Bell-Kareem · Current Topics in Microbiology and Immunology · 2020

Lassa fever: History, causes, effects, and reduction strategies

Promise Tewogbola, Norah Aung · International Journal of One Health · 2020

Showing 16 of 39 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

60

Page views

0

PDF downloads

10

Outbound clicks

39

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.